Galmed Pharmaceuticals EOCN
NASDAQ EOCN
$3.12 +0.05 (+1.60%)
As of: Oct 21, 2026 · 3:44 PM EDT

Galmed Pharmaceuticals (EOCN) Other Non-Current Liabilities (2013 - 2026)

Updated

Galmed Pharmaceuticals' Other Non-Current Liabilities came in at $1.62 million for Q2 2026.

Analysis

Galmed Pharmaceuticals (EOCN) Other Non-Current Liabilities (2013 - 2026) Analysis & Trends

At the end of FY2016, Galmed Pharmaceuticals' Other Non-Current Liabilities was $267,000, up 50.8% from FY2015.

  • Other Non-Current Liabilities carries a three-year compound annual growth rate of -14.6% (FY2013 to FY2016).
  • Going back by year, Other Non-Current Liabilities was $177,000 in FY2015 and $428,000 in FY2013.
  • The Q2 2026 figure represents the lowest quarterly Other Non-Current Liabilities since Q2 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Galmed Pharmaceuticals 1.68 Mn -39.01 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.62 Mn
Jun 30, 2017 150,000.00
Dec 31, 2016 267,000.00
Jun 30, 2016 222,000.00
Dec 31, 2015 177,000.00
Dec 31, 2014 400,000.00
Dec 31, 2013 428,000.00
API Access

Galmed Pharmaceuticals Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=EOCN&period=max&api_key=YOUR_API_KEY